Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors

Molecular Brain Research

Volumn 110, Issue 2, 2003, Pages 267-278

  Todd, Peter K ^a,b   Malter, James S ^a   Mack, Kenneth J ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Barrel cortex; Dendritic protein synthesis; Experience dependent plasticity; Fragile X syndrome

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; CYCLOHEXIMIDE; DIZOCILPINE; FRAGILE X MENTAL RETARDATION PROTEIN; METABOTROPIC RECEPTOR; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOSE RESPONSE; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SOMATOSENSORY CORTEX; STIMULATION; VIBRISSA;

AFFERENT PATHWAYS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; MALE; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; RNA-BINDING PROTEINS; SOMATOSENSORY CORTEX; VIBRISSAE;

EID: 0037456073     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00657-5     Document Type: Article

References (61)

1. Ashley C.T., Sutcliffe J.S., Kunst C.B., Leiner H.A., Eichler E.E., Nelson D.L., Warren S.T. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat. Genet. 4:1993;244-251.
2. Bordi F., Ugolini A. Group I metabotropic glutamate receptors: implications for brain diseases. Prog. Neurobiol. 59:1999;55-79.
3. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107:2001;477-487.
4. Ceman S., Brown V., Warren S.T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19:1999;7925-7932.
5. Christoffersen G.R., Christensen L.H., Harrington N.R., Macphail E.M., Riedel G. Task-specific enhancement of short-term, but not long-term, memory by class I metabotropic glutamate receptor antagonist 1-aminoindan-1,5-dicarboxylic acid in rats. Behav. Brain Res. 101:1999;215-226.
6. Cohen A.S., Raymond C.R., Abraham W.C. Priming of long-term potentiation induced by activation of metabotropic glutamate receptors coupled to phospholipase C. Hippocampus. 8:1998;160-170.
7. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. USA. 94:1997;5401-5404.
8. Conquet F., Bashir Z.I., Davies C.H., Daniel H., Ferraguti F., Bordi F., Franz-Bacon K., Reggiani A., Matarese V., Conde F., et al. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature. 372:1994;237-243.
9. Corbin F., Bouillon M., Fortin A., Morin S., Rousseau F., Khandjian E.W. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6:1997;1465-1472.
10. Davis H.P., Squire L.R. Protein synthesis and memory: a review. Psychol. Bull. 96:1984;518-559.
11. de Vries B.B., Halley D.J., Oostra B.A., Niermeijer M.F. The fragile X syndrome. J. Med. Genet. 35:1998;579-589.
12. de Vries B.B., van den Ouweland A.M., Mohkamsing S., Duivenvoorden H.J., Mol E., Gelsema K., van Rijn M., Halley D.J., Sandkuijl L.A., Oostra B.A., Tibben A., Niermeijer M.F. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am. J. Hum. Genet. 61:1997;660-667.
13. Feng Y., Absher D., Eberhart D.E., Brown V., Malter H.E., Warren S.T. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell. 1:1997;109-118.
14. Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17:1997;1539-1547.
15. Fox K., Schlaggar B.L., Glazewski S., O'Leary D.D. Glutamate receptor blockade at cortical synapses disrupts development of thalamocortical and columnar organization in somatosensory cortex. Proc. Natl. Acad. Sci. USA. 93:1996;5584-5589.
16. Glazewski S., Barth A.L., Wallace H., McKenna M., Silva A., Fox K. Impaired experience-dependent plasticity in barrel cortex of mice lacking the alpha and delta isoforms of CREB. Cereb. Cortex. 9:1999;249-256.
17. Greenough W.T., Klintsova A.Y., Irwin S.A., Galvez R., Bates K.E., Weiler I.J. Synaptic regulation of protein synthesis and the fragile X protein. Proc. Natl. Acad. Sci. USA. 98:2001;7101-7106.
18. Hannan A.J., Blakemore C., Katsnelson A., Vitalis T., Huber K.M., Bear M., Roder J., Kim D., Shin H.S., Kind P.C. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat. Neurosci. 4:2001;282-288.
19. Huber K.M., Gallagher S.M., Warren S.T., Bear M. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA. 99:2002;7746-7750.
20. Huber K.M., Kayser M.S., Bear M.F. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science. 288:2000;1254-1257.
21. Huttner W.B., Schiebler W., Greengard P., De Camilli P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 96:1983;1374-1388.
22. Ichise T., Kano M., Hashimoto K., Yanagihara D., Nakao K., Shigemoto R., Katsuki M., Aiba A. mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science. 288:2000;1832-1835.
23. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., Kooy F., Willems P.J., Cras P., Kozlowski P.B., Swain R.A., Weiler I.J., Greenough W.T. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet. 98:2001;161-167.
24. Irwin S.A., Swain R.A., Christmon C.A., Chakravarti A., Weiler I.J., Greenough W.T. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 73:2000;87-93.
25. Irwin S.A., Swain R.A., Christmon C.A., Chakravarti A., Weiler I.J., Greenough W.T. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 74:2000;87-93.
26. Karachot L., Shirai Y., Vigot R., Yamamori T., Ito M. Induction of long-term depression in cerebellar Purkinje cells requires a rapidly turned over protein. J. Neurophysiol. 86:2001;280-289.
27. Knott G.W., Quairiaux C., Genoud C., Welker E. Formation of dendritic spines with GABAergic synapses induced by whisker stimulation in adult mice. Neuron. 34:2002;265-273.
28. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10:2001;329-338.
29. Li J., Pelletier M.R., Perez Velazquez J.L., Carlen P.L. Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency. Mol. Cell. Neurosci. 19:2002;138-151.
30. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29:2001;2276-2283.
31. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., Roder J.C. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17:1997;5196-5205.
32. Mack K.J., Yi S.D., Chang S., Millan N., Mack P. NGFI-C expression is affected by physiological stimulation and seizures in the somatosensory cortex. Brain Res. Mol. Brain Res. 29:1995;140-146.
33. Maggi C.A., Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: General considerations. Experientia. 42:1986;109-114.
34. McDonald J.W., Silverstein F.S., Cardona D., Hudson C., Chen R., Johnston M.V. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience. 36:1990;589-599.
35. Merlin L.R., Bergold P.J., Wong R.K. Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. J. Neurophysiol. 80:1998;989-993.
36. Merlin L.R., Wong R.K. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J. Neurophysiol. 78:1997;539-544.
37. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 98:1999;427-436.
38. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
39. Nanda S., Mack K.J. Multiple promoters direct stimulus and temporal specific expression of brain-derived neurotrophic factor in the somatosensory cortex. Brain Res. Mol. Brain Res. 62:1998;216-219.
40. Nanda S.A., Mack K.J. Seizures and sensory stimulation result in different patterns of brain derived neurotrophic factor protein expression in the barrel cortex and hippocampus. Brain Res. Mol. Brain Res. 78:2000;1-14.
41. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21:2001;5139-5146.
42. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boue J., Bertheas M.F., Mandel J.L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 252:1991;1097-1102.
43. Parrish J.E., Oostra B.A., Verkerk A.J., Richards C.S., Reynolds J., Spikes A.S., Shaffer L.G., Nelson D.L. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet. 8:1994;229-235.
44. Raymond C.R., Thompson V.L., Tate W.P., Abraham W.C. Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. J. Neurosci. 20:2000;969-976.
45. Rema V., Armstrong-James M., Ebner F.F. Experience-dependent plasticity of adult rat S1 cortex requires local NMDA receptor activation. J. Neurosci. 18:1998;10196-10206.
46. Rocamora N., Welker E., Pascual M., Soriano E. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. J. Neurosci. 16:1996;4411-4419.
47. Rudelli R.D., Brown W.T., Wisniewski K., Jenkins E.C., Laure-Kamionowska M., Connell F., Wisniewski H.M. Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol. (Berl.). 67:1985;289-295.
48. Schaeffer C., Bardoni B., Mandel J.L., Ehresmann B., Ehresmann C., Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20:2001;4803-4813.
49. Schomberg S.L., Su G., Haworth R.A., Sun D. Stimulation of Na-K-2Cl cotransporter in neurons by activation of Non-NMDA ionotropic receptor and group-I mGluRs. J. Neurophysiol. 85:2001;2563-2575.
50. Segal D.S., Squire L.R., Barondes S.H. Cycloheximide: its effects on activity are dissociable from its effects on memory. Science. 172:1971;82-84.
51. Snyder E.M., Philpot B.D., Huber K.M., Dong X., Fallon J.R., Bear M.F. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4:2001;1079-1085.
52. Tizzano J.P., Griffey K.I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
53. Todd P.K., Mack K.J. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Brain Res. Mol. Brain Res. 80:2000;17-25.
54. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64:1996;196-197.
55. Verheij C., Bakker C.E., de Graaff E., Keulemans J., Willemsen R., Verkerk A.J., Galjaard H., Reuser A.J., Hoogeveen A.T., Oostra B.A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363:1993;722-724.
56. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:1991;905-914.
57. Vincent A., Heitz D., Petit C., Kretz C., Oberle I., Mandel J.L. Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature. 349:1991;624-626.
58. Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D., Miyashiro K., Comery T.A., Patel B., Eberwine J., Greenough W.T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA. 94:1997;5395-5400.
59. Welker E., Soriano E., Dorfl J., Van der Loos H. Plasticity in the barrel cortex of the adult mouse: transient increase of GAD-immunoreactivity following sensory stimulation. Exp. Brain Res. 78:1989;659-664.
60. Xiao M.Y., Zhou Q., Nicoll R.A. Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors. Neuropharmacology. 41:2001;664-671.
61. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., Holman K., Mulley J.C., Warren S.T., Schlessinger D., et al. Fragile X genotype characterized by an unstable region of DNA. Science. 252:1991;1179-1181.